IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303 | +102.0% | 7,901 | 0.0% | 0.00% | +200.0% |
| Q2 2023 | $150 | +105.5% | 7,901 | +68.8% | 0.00% | 0.0% |
| Q1 2023 | $73 | -29.8% | 4,680 | -19.9% | 0.00% | 0.0% |
| Q4 2022 | $104 | -99.6% | 5,844 | +15.0% | 0.00% | – |
| Q3 2022 | $28,000 | +40.0% | 5,080 | 0.0% | 0.00% | – |
| Q2 2022 | $20,000 | -39.4% | 5,080 | -14.5% | 0.00% | – |
| Q1 2022 | $33,000 | -87.8% | 5,943 | +1.7% | 0.00% | -100.0% |
| Q4 2020 | $270,000 | – | 5,841 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |